Skip to main content

Harmony Biosciences Holdings, Inc 8-K/A, filed Oct 30, 2026

Harmony Biosciences Holdings, Inc. (HRMY)

8-K/A 2026-10-30 For: 2026-10-12
View Original
Added on October 30, 2026

About this 8-K/A

Harmony Biosciences Holdings, Inc filed this 8-K/A on October 30, 2026, reporting on events of October 12, 2026.

Harmony Biosciences Holdings, Inc. said Jeffrey M. Dayno will retire as CEO effective December 31, 2026, receive $770,000, and be succeeded by Peter Anastasiou effective January 1, 2027. Anastasiou’s salary will be $725,000, with equity awards of $1,750,000 and $750,000. AI summary

Items reported

  • Item 5.02: Director or officer change, or executive pay
  • Item 9.01: Financial statements and exhibits